HRMY NASDAQ
Harmony Biosciences Holdings, Inc.
1W: +1.0%
1M: +3.1%
3M: -13.7%
YTD: -18.6%
1Y: -13.2%
3Y: -15.8%
5Y: +12.2%
$31.25
+0.81 (+2.68%)
Weekly Expected Move ±6.2%
$26
$28
$30
$32
$34
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.8B
52W Range25.52-40.87
Volume700,513
Avg Volume993,360
Beta0.96
Dividend—
Analyst Ratings
Company Info
CEOJeffrey Dayno
Employees268
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-19
Websiteharmonybiosciences.com
630 West Germantown Pike
Plymouth Meeting, PA 19462
US
Plymouth Meeting, PA 19462
US
484 539 9800
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Latest News
A beaten-down biotech just lost a meaningful backer — should you care?
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised
Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?
Harmony outlines $1B-$1.04B 2026 net revenue plan while targeting pitolisant GR PDUFA in Q1 2027
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Szyper Linda M | A-Award | 21,872 | $30.76 | 2026-05-14 |
| Philip Ron M | A-Award | 21,872 | $30.76 | 2026-05-14 |
| Graf R. Mark | A-Award | 21,872 | $30.76 | 2026-05-14 |
| Sabater Juan A. | A-Award | 21,872 | $30.76 | 2026-05-14 |
| Sender Gary | A-Award | 21,872 | $30.76 | 2026-05-14 |